BACKGROUND/AIMS: While the Cl(-) efflux assays are relatively straightforward, their ability to assess the efficacy of phenotypic correction in cystic fibrosis (CF) tissue or cells may be limited. Accurate assessment of therapeutic efficacy, i.e., correlating wild type CF transmembrane conductance regulator (CFTR) levels with phenotypic correction in tissue or individual cells, requires a sensitive assay. METHODS: Radioactive chloride ((36)Cl) efflux was compared to Ussing chamber analysis for measuring cAMP-dependent Cl(-) transport in mixtures of human normal (16HBE14o-) and cystic fibrosis (CF) (CFTE29o- or CFBE41o-, respectively) airway epithelial cells. Cell mixtures with decreasing amounts of 16HBE14o- cells were evaluated. RESULTS: Efflux and Ussing chamber studies on mixed populations of normal and CF airway epithelial cells showed that, as the number of CF cells within the population was progressively increased, the cAMP-dependent Cl(-) decreased. The (36)Cl efflux assay was effective for measuring Cl(-) transport when ≥ 25% of the cells were normal. If < 25% of the cells were phenotypically wild-type (wt), the (36)Cl efflux assay was no longer reliable. Polarized CFBE41o- cells, also homozygous for the ΔF508 mutation, were used in the Ussing chamber studies. Ussing analysis detected cAMP-dependent Cl(-) currents in mixtures with ≥1% wild-type cells indicating that Ussing analysis is more sensitive than (36)Cl efflux analysis for detection of functional CFTR. CONCLUSIONS: Assessment of CFTR function by Ussing analysis is more sensitive than (36)Cl efflux analysis. Ussing analysis indicates that cell mixtures containing 10% 16HBE14o- cells showed 40-50% of normal cAMP-dependent Cl(-) transport that drops off exponentially between 10-1% wild-type cells.
BACKGROUND/AIMS: While the Cl(-) efflux assays are relatively straightforward, their ability to assess the efficacy of phenotypic correction in cystic fibrosis (CF) tissue or cells may be limited. Accurate assessment of therapeutic efficacy, i.e., correlating wild type CF transmembrane conductance regulator (CFTR) levels with phenotypic correction in tissue or individual cells, requires a sensitive assay. METHODS:Radioactive chloride ((36)Cl) efflux was compared to Ussing chamber analysis for measuring cAMP-dependent Cl(-) transport in mixtures of human normal (16HBE14o-) and cystic fibrosis (CF) (CFTE29o- or CFBE41o-, respectively) airway epithelial cells. Cell mixtures with decreasing amounts of 16HBE14o- cells were evaluated. RESULTS: Efflux and Ussing chamber studies on mixed populations of normal and CF airway epithelial cells showed that, as the number of CF cells within the population was progressively increased, the cAMP-dependent Cl(-) decreased. The (36)Cl efflux assay was effective for measuring Cl(-) transport when ≥ 25% of the cells were normal. If < 25% of the cells were phenotypically wild-type (wt), the (36)Cl efflux assay was no longer reliable. Polarized CFBE41o- cells, also homozygous for the ΔF508 mutation, were used in the Ussing chamber studies. Ussing analysis detected cAMP-dependent Cl(-) currents in mixtures with ≥1% wild-type cells indicating that Ussing analysis is more sensitive than (36)Cl efflux analysis for detection of functional CFTR. CONCLUSIONS: Assessment of CFTR function by Ussing analysis is more sensitive than (36)Cl efflux analysis. Ussing analysis indicates that cell mixtures containing 10% 16HBE14o- cells showed 40-50% of normal cAMP-dependent Cl(-) transport that drops off exponentially between 10-1% wild-type cells.
Authors: M Chanson; P Y Berclaz; I Scerri; T Dudez; K Wernke-Dollries; L Pizurki; A Pavirani; M A Fiedler; S Suter Journal: Am J Pathol Date: 2001-05 Impact factor: 4.307
Authors: Estelle Cormet-Boyaka; Michael Jablonsky; Anjaparavanda P Naren; Patricia L Jackson; Donald D Muccio; Kevin L Kirk Journal: Proc Natl Acad Sci U S A Date: 2004-05-12 Impact factor: 11.205
Authors: Felix Munkonge; Eric W F W Alton; Charlotte Andersson; Heather Davidson; Anca Dragomir; Aleksander Edelman; Ray Farley; Lena Hjelte; Gerry McLachlan; Myra Stern; Godfried M Roomans Journal: J Cyst Fibros Date: 2004-08 Impact factor: 5.482
Authors: Jason Powell; Bernard Verdon; Janet A Wilson; A John Simpson; Jeffery Pearson; Chris Ward Journal: Laryngoscope Date: 2019-01-08 Impact factor: 2.970
Authors: Shingo Suzuki; R Geoffrey Sargent; Beate Illek; Horst Fischer; Alaleh Esmaeili-Shandiz; Michael J Yezzi; Albert Lee; Yanu Yang; Soya Kim; Peter Renz; Zhongxia Qi; Jingwei Yu; Marcus O Muench; Ashley I Beyer; Alessander O Guimarães; Lin Ye; Judy Chang; Eli J Fine; Thomas J Cradick; Gang Bao; Meghdad Rahdar; Matthew H Porteus; Tsuyoshi Shuto; Hirofumi Kai; Yuet W Kan; Dieter C Gruenert Journal: Mol Ther Nucleic Acids Date: 2016-01-05 Impact factor: 10.183